RadioMedix - Crunchbase Company Profile & Funding

Q: Where is RadioMedix's headquarters?

RadioMedix is located in Houston, Texas, United States.

Q: Who invested in RadioMedix?

RadioMedix is funded by Portland Investment Counsel.

Q: When was the last funding round for RadioMedix?

RadioMedix closed its last funding round on obfuscated from a Series A round.

Q: How much funding has RadioMedix raised to date?

RadioMedix has raised obfuscated.

Overview

RadioMedix

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About RadioMedix

CB Rank

11276

RadioMedix is a privately held biotechnology company

Founded

obfuscation

Private

Series A

Houston, Texas, United States

11-50

radiomedix.com/

Biotechnology

Health Care

Funding Rounds

Series A

OBF

obfuscation

Key People

Izabela Tworowska: Chief Scientific Officer, BOD
Past Role: Rice University, Postdoctoral Research Associate
Azar Delpassand: President

Details

Legal Name

RadioMedix, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Ebrahim Delpassand, Izabela Tworowska

About the Company

RadioMedix is a privately held biotechnology company focused on innovative new targeted radiopharmaceuticals for diagnosis and therapy of cancer.

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

RadioMedix is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

AlphaMedix™

A targeted alpha-emitter therapy using Pb-212 for treating metastatic or inoperable somatostatin receptor-positive neuroendocrine tumors.

DetectNET™

A Cu-64 labeled DOTATATE diagnostic agent for PET/CT imaging of somatostatin receptor-positive neuroendocrine tumors.

Research & Development

RadioMedix is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A
obfuscated obfuscation	Series A - RadioMedix	1	obfuscated obfuscation	Portland Investment Counsel	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Portland Investment Counsel	Yes	Series A - RadioMedix	Michael Chin
Portland Investment Counsel	Yes	Series A - RadioMedix	Michael Chin
Portland Investment Counsel	Yes	Series A - RadioMedix	Michael Chin
Portland Investment Counsel	Yes	Series A - RadioMedix	Michael Chin
Portland Investment Counsel	Yes	Series A - RadioMedix	Michael Chin